Close menu



Obinutuzumab-like – Labelled (Arg,Lys) 13C15N


Quantification of Obinutuzumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Obinutuzumab-like is a recombinant, stable isotope labelled monoclonal IgG1-Kappaantibody containing proteotypic peptides derived from Obinutuzumab’s originator sequence. Labelled Obinutuzumab-like is designed for use as an internal standard for quantitative analysis of Obinutuzumab in plasma samples. Obinutuzumab targets the CD20 protein and is used in hematology and inflammatory diseases.

This product is for research use only and is not intended for diagnostic or therapeutic use.